¼¼°èÀÇ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ÀǾàǰ ½ÃÀå : ¿¹Ãø(2025-2030³â)
Global Hydroxychloroquine Drugs Market - Forecasts from 2025 to 2030
»óǰÄÚµå
:
1649523
¸®¼Ä¡»ç
:
Knowledge Sourcing Intelligence
¹ßÇàÀÏ
:
2025³â 01¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 145 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ÀǾàǰ ½ÃÀåÀº CAGR 2.62%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 2025³â 11¾ï 7,400¸¸ ´Þ·¯¿¡¼ 2030³â¿¡´Â 13¾ï 3,600¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄýÀº Ç׸»¶ó¸®¾ÆÁ¦ÀÌ¸ç ¸»¶ó¸®¾Æ³ª ·ù¸¶Æ¼½º °üÀý¿°, ·çǪ½º µî ÀÚ°¡¸é¿ªÁúȯÀÇ Ä¡·á¿¡ ÀÚÁÖ »ç¿ëµË´Ï´Ù. ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄýÀº ¿°ÁõÀ» ¾ïÁ¦ÇÏ°í ¸é¿ª°è¸¦ Á¶ÀýÇÔÀ¸·Î½á ÀÚ°¡¸é¿ª ÁúȯÀÇ À翬À» ¾ïÁ¦ÇÏ°í ¸»¶ó¸®¾Æ ±â»ýÃæÀÇ Áõ½ÄÀ» ¾ïÁ¦ÇÕ´Ï´Ù. Àü¹ÝÀûÀ¸·Î, ÇÏÀ̵å·Ï½ÃŬ·Î·ÎŲÀº ¾çÈ£ÇÑ ºÎÀÛ¿ë ÇÁ·ÎÆÄÀÏÀ» º¸À¯ÇÏÁö¸¸, ¶§¶§·Î À§ÀåÀÇ ¿°Áõ ¹× ÇǺΠ¹ßÁøÀ» À¯¹ßÇÒ ¼ö ÀÖÀ¸¸ç, ¸¸¼ºÀûÀÎ »ç¿ëÀº ¸Á¸· Àå¾Ö¸¦ À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄýÀº COVID-19ÀÇ ´ëÀ¯Çà ½Ã Å« °ü½ÉÀ» ²ø¾úÁö¸¸, ±× È¿´ÉÀº Á¦ÇÑµÈ ÀÓ»ó½ÃÇè¿¡¼¸¸ È®ÀεǾú½À´Ï´Ù. ´Ù¾çÇÑ ¸¸¼º ÁúȯÀ» °ü¸®Çϱâ À§ÇÑ ±ÍÁßÇÑ ¼±ÅÃÀÌ µÇ´Â °Í¿¡´Â º¯ÇÔÀÌ ¾øÀ¸¸ç, Àå±â°£ »ç¿ë°ú °ü·ÃµÈ ºÎÀÛ¿ëÀÇ °¡´É¼ºÀÌ ÀÖÀ¸¹Ç·Î ½ÅÁßÇÑ ¸ð´ÏÅ͸µÀÌ ÇʼöÀûÀÔ´Ï´Ù.
¼¼°èÀÇ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ÀǾàǰ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ¸¸¼º ÁúȯÀÇ ÀÌȯÀ² Áõ°¡ : ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ¼ö¿ä´Â ·ù¸¶Æ¼½º °üÀý¿°, ·çǪ½º, ¸»¶ó¸®¾Æ¿Í °°Àº ¸¸¼º ÁúȯÀÇ ÀÌȯÀ² Áõ°¡·Î À̾îÁý´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)´Â ´Ù¾çÇÑ ¼öÁØÀÇ ÅëÁõ°ú Àå¾Ö¸¦ ÀÏÀ¸Å³ ¼ö ÀÖ´Â 150°³ ÀÌ»óÀÇ ·ù¸¶Æ¼½º ¶Ç´Â ±Ù°ñ°Ý°è ÁúȯÀ» È®ÀÎÇÕ´Ï´Ù. ·ù¸¶Æ¼½º °üÀý¿°Àº Àα¸ÀÇ ¾à 0.1%¿¡¼ 0.3%°¡ º´À» ¾Î°í ÀÖÀ¸¸ç ¼±Áø±¹¿¡¼´Â ÁÖ·Î ¿©¼ºÀÌ ¾Î°í ÀÖ½À´Ï´Ù.
¸»¶ó¸®¾Æ´Â ¿©ÀüÈ÷ ¼¼°èÀûÀ¸·Î °¡Àå È®»êµÈ Áúº´ Áß ÇϳªÀ̸ç ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄýÀ¸·Î È¿°úÀûÀ¸·Î Ä¡·áµË´Ï´Ù. World Malaria Report 2024¿¡ µû¸£¸é 2023³â ¼¼°è ¸»¶ó¸®¾Æ ȯÀÚ ¼ö´Â 2¾ï 6,300¸¸ ¸íÀ¸·Î Àü³âº¸´Ù Áõ°¡Çß½À´Ï´Ù. °°Àº ÇØ »ç¸ÁÀÚ ¼ö´Â ¾à 59¸¸ 7,000¸íÀ̾ú½À´Ï´Ù.
Áö¸®Àû ÀλçÀÌÆ®
¼¼°èÀÇ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ÀǾàǰ ½ÃÀåÀº 5°³ Áö¿ªÀ¸·Î ±¸ºÐµË´Ï´Ù. ºÏ¹Ì, ³²¹Ì, À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«, ¾Æ½Ã¾ÆÅÂÆò¾çÀÔ´Ï´Ù.
- ºÏ¹Ì : ºÏ¹ÌÀÇ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ÀǾàǰ ½ÃÀåÀº ÁÖ·Î ·ù¸¶Æ¼½º °üÀý¿°°ú ·çǪ½º¿Í °°Àº ÀÚ°¡¸é¿ª ÁúȯÀÇ ³ôÀº À¯º´·ü¿¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. ÀÎÁöµµÀÇ Çâ»ó°ú Áø´Ü ´É·ÂÀÇ Çâ»óÀÌ ¼ö¿ä¸¦ ´õ¿í ³ôÀ̰í ÀÖ½À´Ï´Ù. ÀÇ·á ÀÎÇÁ¶ó°¡ ¹ß´ÞÇÔ¿¡ µû¶ó ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý¿¡ ½±°Ô Á¢±ÙÇÒ ¼ö ÀÖ´Â ¹Ý¸é, ÇöÀç ÁøÇà ÁßÀÎ ¿¬±¸´Â ÀÌ ¾à¹°ÀÇ »õ·Î¿î ¿ëµµ¸¦ ¸ð»öÇϰí ÀÖ½À´Ï´Ù.
- ¾Æ½Ã¾ÆÅÂÆò¾ç : ÀÌ Áö¿ª¿¡¼ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ¼ö¿ä´Â ƯÈ÷ Àεµ, Àεµ³×½Ã¾Æ, Çʸ®Çɰú °°Àº ±¹°¡¿¡¼ ¸»¶ó¸®¾ÆÀÇ ³ôÀº ºÎ´ã¿¡ Å©°Ô ¿µÇâÀ» ¹Þ°í ÀÖÀ¸¸ç, ¸»¶ó¸®¾ÆÀÇ ¿¹¹æ ¹× Ä¡·á Àü·«¿¡¼ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù.
Á¾ÇÕÇϸé, ¼¼°èÀÇ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ÀǾàǰ ½ÃÀåÀº ¸¸¼º Áúȯ°ú ¸»¶ó¸®¾ÆÀÇ ÀÌȯÀ²ÀÇ »ó½Â¿¡ ´õÇØ, ´Ù¾çÇÑ Áö¿ª¿¡¼ÀÇ ÇコÄɾî ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÀǽÄÀÇ °íÁ¶³ª Áøº¸¿¡ ÀÇÇØ ¼ºÀåÀÌ Àü¸ÁµÇ°í ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼¸¦ ±¸ÀÔÇÏ´Â ÀÌÀ¯
- ÀλçÀÌÆ® ÀÖ´Â ºÐ¼® : °í°´ ºÎ¹®, Á¤ºÎ Á¤Ã¥ ¹× »çȸ°æÁ¦ ¿äÀÎ, ¼ÒºñÀÚ ¼±È£, »ê¾÷º° ¹× ±âŸ ÇÏÀ§ ºÎ¹®¿¡ ÁßÁ¡À» µÎ¾î ÁÖ¿ä ¹× ½ÅÈï Áö¿ªÀ» ´Ù·ç´Â »ó¼¼ÇÑ ½ÃÀå °í·Á»çÇ×À» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.
- °æÀï ±¸µµ : ¼¼°è ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÏ´Â Àü·«Àû Àü·«À» ÀÌÇØÇϰí ÀûÀýÇÑ Àü·«À¸·Î ½ÃÀå ħÅõ °¡´É¼ºÀ» ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.
- ½ÃÀå µ¿Çâ ¹× ÃËÁø¿äÀÎ : µ¿Àû ¿äÀΰú ¸Å¿ì Áß¿äÇÑ ½ÃÀå µ¿Çâ, ±×¸®°í ±×µéÀÌ ÇâÈÄ ½ÃÀå Àü°³¸¦ ¾î¶»°Ô Çü¼ºÇØ ³ª°¡´ÂÁö¸¦ ޱ¸ÇÕ´Ï´Ù.
- ½ÇÇà °¡´ÉÇÑ Á¦¾È : ¿ªµ¿ÀûÀΠȯ°æ¿¡¼ »õ·Î¿î ºñÁî´Ï½º ½ºÆ®¸²°ú ¼öÀÍÀ» ¹ß±¼Çϱâ À§ÇÑ Àü·«Àû °áÁ¤À» ³»¸®±â À§ÇØ ÀλçÀÌÆ®¸¦ Ȱ¿ëÇÕ´Ï´Ù.
- Æø³ÐÀº ÀÌ¿ëÀÚ¿¡ ´ëÀÀ : ½ÅÈï±â¾÷, ¿¬±¸±â°ü, ÄÁ¼³ÅÏÆ®, Áß¼Ò±â¾÷, ´ë±â¾÷¿¡ À¯ÀÍÇÏ°í ºñ¿ë È¿À²ÀûÀÔ´Ï´Ù.
¾î¶² ¿ëµµ·Î »ç¿ëµË´Ï±î?
¾÷°è ¹× ½ÃÀå ÀλçÀÌÆ®, »ç¾÷ ±âȸ Æò°¡, Á¦Ç° ¼ö¿ä ¿¹Ãø, ½ÃÀå ÁøÃâ Àü·«, Áö¸®Àû È®´ë, ¼³ºñ ÅõÀÚ °áÁ¤, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ© ¹× ¿µÇâ, ½ÅÁ¦Ç° °³Ã´, °æÀïÀÇ ¿µÇâ
Á¶»ç ¹üÀ§
- ½ÇÀû µ¥ÀÌÅÍ ¹× ¿¹Ãø(2022-2030³â)
- ¼ºÀå ±âȸ, °úÁ¦, °ø±Þ¸Á Àü¸Á, ±ÔÁ¦ Ʋ, °í°´ Çൿ, µ¿Ç⠺м®
- °æÀï Æ÷Áö¼Å´×, Àü·«, ½ÃÀå Á¡À¯À² ºÐ¼®
- ºÎ¹® ¹× °¢±¹À» Æ÷ÇÔÇÑ Áö¿ªÀÇ ¼öÀÍ ¼ºÀå ¹× ¿¹Ãø ºÐ¼®
- ±â¾÷ÇÁ·ÎÆÄÀÏ ¸µ(Àü·«, Á¦Ç°, À繫 »óȲ, ÁÖ¿ä ¹ßÀü µî)
¸ñÂ÷
Á¦1Àå ¼·Ð
- ½ÃÀå °³¿ä
- ½ÃÀåÀÇ Á¤ÀÇ
- Á¶»ç ¹üÀ§
- ½ÃÀå ¼¼ºÐÈ
- ÅëÈ
- ÀüÁ¦Á¶°Ç
- ±âÁØ¿¬µµ ¹× ¿¹Ãø¿¬µµÀÇ Å¸ÀÓ¶óÀÎ
- ÀÌÇØ °ü°èÀÚ¿¡°Ô ÀÖ¾î¼ ÁÖ¿ä ÀÌÁ¡
Á¦2Àå Á¶»ç ¹æ¹ý
Á¦3Àå ÁÖ¿ä ¿ä¾à
- ÁÖ¿ä Á¶»ç °á°ú
- ¾Ö³Î¸®½ºÆ® º¸±â
Á¦4Àå ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
- Porter's Five Forces ºÐ¼®
- ¾÷°è ¹ë·ùüÀÎ ºÐ¼®
Á¦5Àå ¼¼°èÀÇ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ÀǾàǰ ½ÃÀå : ¿ëµµº°
- ¼¹®
- ·ù¸¶Æ¼½º °üÀý
- ¸»¶ó¸®¾Æ
- ±âŸ
Á¦6Àå ¼¼°èÀÇ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ÀǾàǰ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°
- ¼¹®
- º´¿ø ¹× Áø·á¼Ò
- ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
- ¿¬±¸½Ç
Á¦7Àå ¼¼°èÀÇ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ÀǾàǰ ½ÃÀå : Áö¿ªº°
- ¼¼°è °³¿ä
- ºÏ¹Ì
- ³²¹Ì
- ºê¶óÁú
- ¾Æ¸£ÇîÆ¼³ª
- ±âŸ ³²¹Ì
- À¯·´
- ¿µ±¹
- µ¶ÀÏ
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- ±âŸ À¯·´
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß±¹
- Àεµ
- ÀϺ»
- Çѱ¹
- ´ë¸¸
- ű¹
- Àεµ³×½Ã¾Æ
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
Á¦8Àå °æÀï ȯ°æ ¹× ºÐ¼®
- ÁÖ¿ä ±â¾÷ ¹× Àü·« ºÐ¼®
- ½ÃÀå Á¡À¯À² ºÐ¼®
- ÇÕº´, Àμö, ÇÕÀÇ ¹× Äݶ󺸷¹À̼Ç
- °æÀï ´ë½Ãº¸µå
Á¦9Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ
- Novartis AG
- Sanofi
- Amneal Pharmaceuticals LLC.
- Dr. Reddy's Laboratories
- McKesson Medical-Surgical Inc.
- Laurus Labs Ltd.
- Lupin Pharmaceuticals, Inc.
- Mylan NV
- Apotex
AJY
¿µ¹® ¸ñÂ÷
The global hydroxychloroquine drugs market is projected to grow at a CAGR of 2.62%, from US$1.174 billion in 2025 to US$1.336 billion in 2030.
Hydroxychloroquine is an antimalarial medication commonly used to treat malaria, as well as autoimmune diseases such as rheumatoid arthritis and lupus. It works by inhibiting inflammation and regulating the immune system, which helps reduce flare-ups of autoimmune disorders and suppresses the growth of the malaria parasite. Overall, hydroxychloroquine has a favorable side effect profile; however, it can occasionally cause gastrointestinal irritation and skin rashes, with chronic use potentially leading to retinal damage. The drug gained significant attention during the COVID-19 pandemic, although its effectiveness for this purpose has only been supported by a few limited clinical trials. While it remains a valuable option for managing various chronic conditions, careful monitoring is essential due to possible adverse effects associated with long-term use.
Drivers of the Global Hydroxychloroquine Market:
- Increasing Prevalence of Chronic Conditions: The demand for hydroxychloroquine is being driven by the rising incidence of chronic conditions such as rheumatoid arthritis, lupus, and malaria. The World Health Organization (WHO) identifies over 150 rheumatic or musculoskeletal diseases that can cause varying levels of pain and disability. Rheumatoid arthritis affects approximately 0.1% to 0.3% of the population, predominantly women in developed countries, typically between the ages of 20 and 40.
Malaria remains one of the most widespread diseases globally, treated effectively with hydroxychloroquine. According to the World Malaria Report 2024, there were an estimated 263 million cases of malaria worldwide in 2023, marking an increase from previous years. In that same year, approximately 597,000 deaths were attributed to malaria.
Geographical Insights:
The global hydroxychloroquine market is segmented into five regions: North America, South America, Europe, the Middle East & Africa, and Asia-Pacific.
- North America: The hydroxychloroquine market in North America is primarily driven by a high prevalence of autoimmune diseases such as rheumatoid arthritis and lupus that require long-term management with this medication. Increased awareness and improved diagnostic capabilities further enhance demand. The advanced healthcare infrastructure ensures easy access to hydroxychloroquine, while ongoing research explores new applications for the drug.
- Asia-Pacific: In this region, demand for hydroxychloroquine is largely influenced by a high burden of malaria, particularly in countries like India, Indonesia, and the Philippines where it plays a crucial role in malaria prevention and treatment strategies.
In summary, the global hydroxychloroquine market is expected to grow due to rising rates of chronic diseases and malaria, alongside increased awareness and advancements in healthcare infrastructure across various regions.
Reasons for buying this report:-
- Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
- Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
- Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
- Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
- Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
Report Coverage:
- Historical data & forecasts from 2022 to 2030
- Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
- Competitive Positioning, Strategies, and Market Share Analysis
- Revenue Growth and Forecast Assessment of segments and regions including countries
- Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)
The global Hydroxychloroquine drugs market is segmented and analyzed as follows:
By Application
- Rheumatoid Arthritis
- Malaria
- Others
By End-User
- Hospitals and Clinics
- Ambulatory Surgical Centres
- Research Labs
By Geography
- North America
- USA
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Rest of South America
- Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Middle East and Africa
- Saudi Arabia
- UAE
- Rest of the Middle East and Africa
- Asia Pacific
- China
- India
- Japan
- South Korea
- Taiwan
- Thailand
- Indonesia
- Rest of Asia-Pacific
TABLE OF CONTENTS
1. INTRODUCTION
- 1.1. Market Overview
- 1.2. Market Definition
- 1.3. Scope of the Study
- 1.4. Market Segmentation
- 1.5. Currency
- 1.6. Assumptions
- 1.7. Base and Forecast Years Timeline
- 1.8. Key benefits for the stakeholders
2. RESEARCH METHODOLOGY
- 2.1. Research Design
- 2.2. Research Process
3. EXECUTIVE SUMMARY
- 3.1. Key Findings
- 3.2. Analyst View
4. MARKET DYNAMICS
- 4.1. Market Drivers
- 4.2. Market Restraints
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. The Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
- 4.4. Industry Value Chain Analysis
5. GLOBAL HYDROXYCHLOROQUINE DRUGS MARKET BY APPLICATION
- 5.1. Introduction
- 5.2. Rheumatoid Arthritis
- 5.3. Malaria
- 5.4. Others
6. GLOBAL HYDROXYCHLOROQUINE DRUGS MARKET BY END-USER
- 6.1. Introduction
- 6.2. Hospitals and Clinics
- 6.3. Ambulatory Surgical Centres
- 6.4. Research Labs
7. GLOBAL HYDROXYCHLOROQUINE DRUGS MARKET BY GEOGRAPHY
- 7.1. Global Overview
- 7.2. North America
- 7.2.1. United States
- 7.2.2. Canada
- 7.2.3. Mexico
- 7.3. South America
- 7.3.1. Brazil
- 7.3.2. Argentina
- 7.3.3. Rest of South America
- 7.4. Europe
- 7.4.1. United Kingdom
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Italy
- 7.4.5. Spain
- 7.4.6. Rest of Europe
- 7.5. Middle East and Africa
- 7.5.1. Saudi Arabia
- 7.5.2. United Arab Emirates
- 7.5.3. Rest of Middle East and Africa
- 7.6. Asia-Pacific
- 7.6.1. China
- 7.6.2. India
- 7.6.3. Japan
- 7.6.4. South Korea
- 7.6.5. Taiwan
- 7.6.6. Thailand
- 7.6.7. Indonesia
- 7.6.8. Rest of Asia-Pacific
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
- 8.1. Major Players and Strategy Analysis
- 8.2. Market Share Analysis
- 8.3. Mergers, Acquisitions, Agreements, and Collaborations
- 8.4. Competitive Dashboard
9. COMPANY PROFILES
- 9.1. Novartis AG
- 9.2. Sanofi
- 9.3. Amneal Pharmaceuticals LLC.
- 9.4. Dr. Reddy's Laboratories
- 9.5. McKesson Medical-Surgical Inc.
- 9.6. Laurus Labs Ltd.
- 9.7. Lupin Pharmaceuticals, Inc.
- 9.8. Mylan N.V.
- 9.9. Apotex
°ü·ÃÀÚ·á